15 / 46
Enzalutamide
160 mg QD
+ LHRHa
(or orchidectomy)
until progression
n=1125
Metastatic prostate cancer
ECOG 0–2
Commencing ADT
NSAA + LHRHa
(or orchidectomy)
until progression
R
1:1
Phase III Randomized study in mHSPC
|
|
15 / 46
15 / 46
Enzalutamide
160 mg QD
+ LHRHa
(or orchidectomy)
until progression
n=1125
Metastatic prostate cancer
ECOG 0–2
Commencing ADT
NSAA + LHRHa
(or orchidectomy)
until progression
R
1:1
Phase III Randomized study in mHSPC